Loading…

Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop

Protection against hypoxia injury is an important therapeutic strategy for treating hypertensive nephropathy. In this study, the effects of Qian Yang Yu Yin granule (QYYY) on spontaneously hypertensive rats fed with high salt diet and HEK293T cells exposed to hypoxia were investigated. After eight w...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2021-06, Vol.12, p.667433-667433
Main Authors: Qian, Lichao, Ren, Shuai, Xu, Zhongchi, Zheng, Yawei, Wu, Lihua, Yang, Ying, Wang, Yixuan, Li, Jie, Yan, Shihai, Fang, Zhuyuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853
cites cdi_FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853
container_end_page 667433
container_issue
container_start_page 667433
container_title Frontiers in pharmacology
container_volume 12
creator Qian, Lichao
Ren, Shuai
Xu, Zhongchi
Zheng, Yawei
Wu, Lihua
Yang, Ying
Wang, Yixuan
Li, Jie
Yan, Shihai
Fang, Zhuyuan
description Protection against hypoxia injury is an important therapeutic strategy for treating hypertensive nephropathy. In this study, the effects of Qian Yang Yu Yin granule (QYYY) on spontaneously hypertensive rats fed with high salt diet and HEK293T cells exposed to hypoxia were investigated. After eight weeks’ treatment of QYYY, blood pressure, serum creatinine, serum cystatin C, blood urea nitrogen, urinary β2-microglobulin, urinary N-acetyl-β-glucosaminidase, and urinary microalbumin were assessed. The changes of hypoxia-inducible factor-1α (HIF-1α), pyruvate kinase M2 (PKM2), glucose transport 1 (GLUT1), lactate dehydrogenase A (LDH-A), connective tissue growth factor (CTGF), transforming growth factor-β1 (TGF-β1), ATP, lactate, pyruvate, and pathology were also assessed in vivo . HEK293T cells pre-treated with QYYY and/or HIF-1α over expressing cells were cultured in a three gas hypoxic incubator chamber (5% CO 2 , 1% O 2 , 94% N 2 ) for 12 h and then the expressions of HIF-1α, PKM2, GLUT1, LDH-A, CTGF, TGF-β1, ATP, lactate, and pyruvate were detected. Our results showed that QYYY promoted the indicators of renal inflammation and fibrosis mediated by HIF-1α/PKM2 positive feedback loop in vivo and vitro . Our findings indicated that QYYY treated hypertensive nephropathy by regulating metabolic reprogramming mediated by HIF-1α/PKM2 positive feedback loop.
doi_str_mv 10.3389/fphar.2021.667433
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_dc374d18766e453eb5810feabf001c45</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dc374d18766e453eb5810feabf001c45</doaj_id><sourcerecordid>2545592843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853</originalsourceid><addsrcrecordid>eNpVksFu2zAMho1hw1pkfYDddNwlqWXJsnwZMBRLEyzFuqGXnARKplJltuRJdoC8x15kL7JnmtMUw8oLiZ_kxwP_LHtP8wVjsr62_SPERZEXdCFExRl7lV1SIdi8lrR4_V99kV2ltM-nYHXNBH-bXTBOhSxFfpn9-ubAky34HdmOZOs8uY3gxxbJuutjOGAi39FDS9Z-P8YjCZasjj3GAX1ywRN9nPq7sYXBTYg7HECH1plJnLZ3EbrurDcOBmxO46v1ck7__L6-_3JXkPuQ3OAOSJaIjQbzg2xC6N9lbyy0Ca-e8yx7WH5-uFnNN19v1zefNnPDyorNmS2kkVBrroFxDlZaXhU5Wg3YGKA11dayXKI2UFnESvAGoAYDklJZslm2PmObAHvVR9dBPKoATj0JIe4UxMGZFlVjWMUbKishkJcMdSlpbhG0zXNq-In18czqR91N19EPEdoX0Jcd7x7VLhyULKgUjE6AD8-AGH6OmAbVuWSwbcFjGJMqSl6WdSGnR88yeh41MaQU0f47Q3N18oZ68oY6eUOdvcH-Ar3zr9g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2545592843</pqid></control><display><type>article</type><title>Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop</title><source>PubMed Central Free</source><creator>Qian, Lichao ; Ren, Shuai ; Xu, Zhongchi ; Zheng, Yawei ; Wu, Lihua ; Yang, Ying ; Wang, Yixuan ; Li, Jie ; Yan, Shihai ; Fang, Zhuyuan</creator><creatorcontrib>Qian, Lichao ; Ren, Shuai ; Xu, Zhongchi ; Zheng, Yawei ; Wu, Lihua ; Yang, Ying ; Wang, Yixuan ; Li, Jie ; Yan, Shihai ; Fang, Zhuyuan</creatorcontrib><description>Protection against hypoxia injury is an important therapeutic strategy for treating hypertensive nephropathy. In this study, the effects of Qian Yang Yu Yin granule (QYYY) on spontaneously hypertensive rats fed with high salt diet and HEK293T cells exposed to hypoxia were investigated. After eight weeks’ treatment of QYYY, blood pressure, serum creatinine, serum cystatin C, blood urea nitrogen, urinary β2-microglobulin, urinary N-acetyl-β-glucosaminidase, and urinary microalbumin were assessed. The changes of hypoxia-inducible factor-1α (HIF-1α), pyruvate kinase M2 (PKM2), glucose transport 1 (GLUT1), lactate dehydrogenase A (LDH-A), connective tissue growth factor (CTGF), transforming growth factor-β1 (TGF-β1), ATP, lactate, pyruvate, and pathology were also assessed in vivo . HEK293T cells pre-treated with QYYY and/or HIF-1α over expressing cells were cultured in a three gas hypoxic incubator chamber (5% CO 2 , 1% O 2 , 94% N 2 ) for 12 h and then the expressions of HIF-1α, PKM2, GLUT1, LDH-A, CTGF, TGF-β1, ATP, lactate, and pyruvate were detected. Our results showed that QYYY promoted the indicators of renal inflammation and fibrosis mediated by HIF-1α/PKM2 positive feedback loop in vivo and vitro . Our findings indicated that QYYY treated hypertensive nephropathy by regulating metabolic reprogramming mediated by HIF-1α/PKM2 positive feedback loop.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2021.667433</identifier><identifier>PMID: 34168560</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>HIF-1α ; hypertensive nephropathy ; metabolic reprogramming ; Pharmacology ; PKM2 ; Qian Yang Yu Yin granule</subject><ispartof>Frontiers in pharmacology, 2021-06, Vol.12, p.667433-667433</ispartof><rights>Copyright © 2021 Qian, Ren, Xu, Zheng, Wu, Yang, Wang, Li, Yan and Fang. 2021 Qian, Ren, Xu, Zheng, Wu, Yang, Wang, Li, Yan and Fang</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853</citedby><cites>FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218631/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218631/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Qian, Lichao</creatorcontrib><creatorcontrib>Ren, Shuai</creatorcontrib><creatorcontrib>Xu, Zhongchi</creatorcontrib><creatorcontrib>Zheng, Yawei</creatorcontrib><creatorcontrib>Wu, Lihua</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Wang, Yixuan</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Yan, Shihai</creatorcontrib><creatorcontrib>Fang, Zhuyuan</creatorcontrib><title>Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop</title><title>Frontiers in pharmacology</title><description>Protection against hypoxia injury is an important therapeutic strategy for treating hypertensive nephropathy. In this study, the effects of Qian Yang Yu Yin granule (QYYY) on spontaneously hypertensive rats fed with high salt diet and HEK293T cells exposed to hypoxia were investigated. After eight weeks’ treatment of QYYY, blood pressure, serum creatinine, serum cystatin C, blood urea nitrogen, urinary β2-microglobulin, urinary N-acetyl-β-glucosaminidase, and urinary microalbumin were assessed. The changes of hypoxia-inducible factor-1α (HIF-1α), pyruvate kinase M2 (PKM2), glucose transport 1 (GLUT1), lactate dehydrogenase A (LDH-A), connective tissue growth factor (CTGF), transforming growth factor-β1 (TGF-β1), ATP, lactate, pyruvate, and pathology were also assessed in vivo . HEK293T cells pre-treated with QYYY and/or HIF-1α over expressing cells were cultured in a three gas hypoxic incubator chamber (5% CO 2 , 1% O 2 , 94% N 2 ) for 12 h and then the expressions of HIF-1α, PKM2, GLUT1, LDH-A, CTGF, TGF-β1, ATP, lactate, and pyruvate were detected. Our results showed that QYYY promoted the indicators of renal inflammation and fibrosis mediated by HIF-1α/PKM2 positive feedback loop in vivo and vitro . Our findings indicated that QYYY treated hypertensive nephropathy by regulating metabolic reprogramming mediated by HIF-1α/PKM2 positive feedback loop.</description><subject>HIF-1α</subject><subject>hypertensive nephropathy</subject><subject>metabolic reprogramming</subject><subject>Pharmacology</subject><subject>PKM2</subject><subject>Qian Yang Yu Yin granule</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVksFu2zAMho1hw1pkfYDddNwlqWXJsnwZMBRLEyzFuqGXnARKplJltuRJdoC8x15kL7JnmtMUw8oLiZ_kxwP_LHtP8wVjsr62_SPERZEXdCFExRl7lV1SIdi8lrR4_V99kV2ltM-nYHXNBH-bXTBOhSxFfpn9-ubAky34HdmOZOs8uY3gxxbJuutjOGAi39FDS9Z-P8YjCZasjj3GAX1ywRN9nPq7sYXBTYg7HECH1plJnLZ3EbrurDcOBmxO46v1ck7__L6-_3JXkPuQ3OAOSJaIjQbzg2xC6N9lbyy0Ca-e8yx7WH5-uFnNN19v1zefNnPDyorNmS2kkVBrroFxDlZaXhU5Wg3YGKA11dayXKI2UFnESvAGoAYDklJZslm2PmObAHvVR9dBPKoATj0JIe4UxMGZFlVjWMUbKishkJcMdSlpbhG0zXNq-In18czqR91N19EPEdoX0Jcd7x7VLhyULKgUjE6AD8-AGH6OmAbVuWSwbcFjGJMqSl6WdSGnR88yeh41MaQU0f47Q3N18oZ68oY6eUOdvcH-Ar3zr9g</recordid><startdate>20210607</startdate><enddate>20210607</enddate><creator>Qian, Lichao</creator><creator>Ren, Shuai</creator><creator>Xu, Zhongchi</creator><creator>Zheng, Yawei</creator><creator>Wu, Lihua</creator><creator>Yang, Ying</creator><creator>Wang, Yixuan</creator><creator>Li, Jie</creator><creator>Yan, Shihai</creator><creator>Fang, Zhuyuan</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210607</creationdate><title>Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop</title><author>Qian, Lichao ; Ren, Shuai ; Xu, Zhongchi ; Zheng, Yawei ; Wu, Lihua ; Yang, Ying ; Wang, Yixuan ; Li, Jie ; Yan, Shihai ; Fang, Zhuyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HIF-1α</topic><topic>hypertensive nephropathy</topic><topic>metabolic reprogramming</topic><topic>Pharmacology</topic><topic>PKM2</topic><topic>Qian Yang Yu Yin granule</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qian, Lichao</creatorcontrib><creatorcontrib>Ren, Shuai</creatorcontrib><creatorcontrib>Xu, Zhongchi</creatorcontrib><creatorcontrib>Zheng, Yawei</creatorcontrib><creatorcontrib>Wu, Lihua</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Wang, Yixuan</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Yan, Shihai</creatorcontrib><creatorcontrib>Fang, Zhuyuan</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qian, Lichao</au><au>Ren, Shuai</au><au>Xu, Zhongchi</au><au>Zheng, Yawei</au><au>Wu, Lihua</au><au>Yang, Ying</au><au>Wang, Yixuan</au><au>Li, Jie</au><au>Yan, Shihai</au><au>Fang, Zhuyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2021-06-07</date><risdate>2021</risdate><volume>12</volume><spage>667433</spage><epage>667433</epage><pages>667433-667433</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Protection against hypoxia injury is an important therapeutic strategy for treating hypertensive nephropathy. In this study, the effects of Qian Yang Yu Yin granule (QYYY) on spontaneously hypertensive rats fed with high salt diet and HEK293T cells exposed to hypoxia were investigated. After eight weeks’ treatment of QYYY, blood pressure, serum creatinine, serum cystatin C, blood urea nitrogen, urinary β2-microglobulin, urinary N-acetyl-β-glucosaminidase, and urinary microalbumin were assessed. The changes of hypoxia-inducible factor-1α (HIF-1α), pyruvate kinase M2 (PKM2), glucose transport 1 (GLUT1), lactate dehydrogenase A (LDH-A), connective tissue growth factor (CTGF), transforming growth factor-β1 (TGF-β1), ATP, lactate, pyruvate, and pathology were also assessed in vivo . HEK293T cells pre-treated with QYYY and/or HIF-1α over expressing cells were cultured in a three gas hypoxic incubator chamber (5% CO 2 , 1% O 2 , 94% N 2 ) for 12 h and then the expressions of HIF-1α, PKM2, GLUT1, LDH-A, CTGF, TGF-β1, ATP, lactate, and pyruvate were detected. Our results showed that QYYY promoted the indicators of renal inflammation and fibrosis mediated by HIF-1α/PKM2 positive feedback loop in vivo and vitro . Our findings indicated that QYYY treated hypertensive nephropathy by regulating metabolic reprogramming mediated by HIF-1α/PKM2 positive feedback loop.</abstract><pub>Frontiers Media S.A</pub><pmid>34168560</pmid><doi>10.3389/fphar.2021.667433</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2021-06, Vol.12, p.667433-667433
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_dc374d18766e453eb5810feabf001c45
source PubMed Central Free
subjects HIF-1α
hypertensive nephropathy
metabolic reprogramming
Pharmacology
PKM2
Qian Yang Yu Yin granule
title Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A50%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Qian%20Yang%20Yu%20Yin%20Granule%20Improves%20Renal%20Injury%20of%20Hypertension%20by%20Regulating%20Metabolic%20Reprogramming%20Mediated%20by%20HIF-1%CE%B1/PKM2%20Positive%20Feedback%20Loop&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Qian,%20Lichao&rft.date=2021-06-07&rft.volume=12&rft.spage=667433&rft.epage=667433&rft.pages=667433-667433&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2021.667433&rft_dat=%3Cproquest_doaj_%3E2545592843%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3573-3f28c8a9b4ba344af8f4720efbaedca191bff308ebca7fee764daa9aca811853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2545592843&rft_id=info:pmid/34168560&rfr_iscdi=true